Maternal thrombophilia and adverse pregnancy outcomes

Adi Y. Weintraub; Fernanda Press; Arnon Wiznitzer; Eyal Sheiner

doi:10.1586/17474108.2.2.203

Maternal thrombophilia and adverse pregnancy outcomes

Adi Y. Weintraub, Fernanda Press, Arnon Wiznitzer, Eyal Sheiner

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Thrombophilias are inherited or acquired conditions that predispose an individual to thromboembolism. During pregnancy, maternal thrombophilia has been identified as a major risk factor for adverse pregnancy outcomes (APO), including venous and arterial thrombosis, preeclampsia, placental abruption, intrauterine growth restriction, intrauterine fetal losses and recurrent miscarriages. Although a great body of evidence has accumulated regarding this association, there is still much controversy. In this review, aspects of certain APO and thrombophilia are discussed, as well as prophylactic and therapeutic implications.

Original language	English
Pages (from-to)	203-216
Number of pages	14
Journal	Expert Review of Obstetrics and Gynecology
Volume	2
Issue number	2
DOIs	https://doi.org/10.1586/17474108.2.2.203
State	Published - 1 Mar 2007

Keywords

adverse pregnancy outcomes
antiphospholipid syndrome
low-molecular-weight heparin
thrombophilia

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Reproductive Medicine
Obstetrics and Gynecology
Maternity and Midwifery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1586/17474108.2.2.203

Cite this

@article{db1b45c9b7794e57800e4cb8e614fcd3,

title = "Maternal thrombophilia and adverse pregnancy outcomes",

abstract = "Thrombophilias are inherited or acquired conditions that predispose an individual to thromboembolism. During pregnancy, maternal thrombophilia has been identified as a major risk factor for adverse pregnancy outcomes (APO), including venous and arterial thrombosis, preeclampsia, placental abruption, intrauterine growth restriction, intrauterine fetal losses and recurrent miscarriages. Although a great body of evidence has accumulated regarding this association, there is still much controversy. In this review, aspects of certain APO and thrombophilia are discussed, as well as prophylactic and therapeutic implications.",

keywords = "adverse pregnancy outcomes, antiphospholipid syndrome, low-molecular-weight heparin, thrombophilia",

author = "Weintraub, {Adi Y.} and Fernanda Press and Arnon Wiznitzer and Eyal Sheiner",

year = "2007",

month = mar,

day = "1",

doi = "10.1586/17474108.2.2.203",

language = "English",

volume = "2",

pages = "203--216",

journal = "Expert Review of Obstetrics and Gynecology",

issn = "1747-4108",

publisher = "Expert Reviews Ltd.",

number = "2",

}

TY - JOUR

T1 - Maternal thrombophilia and adverse pregnancy outcomes

AU - Weintraub, Adi Y.

AU - Press, Fernanda

AU - Wiznitzer, Arnon

AU - Sheiner, Eyal

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Thrombophilias are inherited or acquired conditions that predispose an individual to thromboembolism. During pregnancy, maternal thrombophilia has been identified as a major risk factor for adverse pregnancy outcomes (APO), including venous and arterial thrombosis, preeclampsia, placental abruption, intrauterine growth restriction, intrauterine fetal losses and recurrent miscarriages. Although a great body of evidence has accumulated regarding this association, there is still much controversy. In this review, aspects of certain APO and thrombophilia are discussed, as well as prophylactic and therapeutic implications.

AB - Thrombophilias are inherited or acquired conditions that predispose an individual to thromboembolism. During pregnancy, maternal thrombophilia has been identified as a major risk factor for adverse pregnancy outcomes (APO), including venous and arterial thrombosis, preeclampsia, placental abruption, intrauterine growth restriction, intrauterine fetal losses and recurrent miscarriages. Although a great body of evidence has accumulated regarding this association, there is still much controversy. In this review, aspects of certain APO and thrombophilia are discussed, as well as prophylactic and therapeutic implications.

KW - adverse pregnancy outcomes

KW - antiphospholipid syndrome

KW - low-molecular-weight heparin

KW - thrombophilia

UR - http://www.scopus.com/inward/record.url?scp=35649026929&partnerID=8YFLogxK

U2 - 10.1586/17474108.2.2.203

DO - 10.1586/17474108.2.2.203

M3 - Article

AN - SCOPUS:35649026929

SN - 1747-4108

VL - 2

SP - 203

EP - 216

JO - Expert Review of Obstetrics and Gynecology

JF - Expert Review of Obstetrics and Gynecology

IS - 2

ER -

Maternal thrombophilia and adverse pregnancy outcomes

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this